Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Launched by DANA-FARBER CANCER INSTITUTE · Oct 31, 2023

Keywords

ClinConnect Summary

The I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain) trial is a research study designed to see if a smartphone app can help people with advanced cancer manage their pain and keep track of their medications. This app aims to make it easier for patients to report their symptoms and get support for their pain management.

To participate in this study, you need to be at least 21 years old and have either a current or past diagnosis of advanced cancer along with experience of cancer-related pain. Unfortunately, if you have difficulty understanding, speaking, or reading English, or if you have conditions that might make it hard for you to participate, you may not be eligible. The study is not currently recruiting participants, but if you join, you can expect to use the app to help improve your pain management and share your experiences with the research team.

Gender

ALL

Eligibility criteria

• Inclusion Criteria for Participants (Activities 1a, 2a, 3a):
• • Age ≥ 21 years
• • Current or previous diagnosis of advanced cancer
• • Current or previous experience with cancer pain
• Exclusion Criteria for Participants (Activities 1a, 2a, 3a):
• • Inability to understand, speak, or read English
• • Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.